踝关节翻修成形术的生存率与风险评估
该单中心回顾性队列研究纳入116例(117踝)因初次全踝关节成形术失败行翻修术的患者,评估活动平台假体翻修的中长期结局与失败危险因素;翻修踝5、10、15年累积生存率分别为81%、74%、70%,患者报告结局显著改善但未达初次置换的改善程度。
要点
- 翻修全踝关节成形术5、10、15年累积生存率分别为81%、74%、70%。
- 术前合并症、无菌性松动、不稳或囊肿植骨是二次翻修最常见的危险因素。
- 疼痛视觉模拟评分中位数由术前6分降至末次随访2分,AOFAS踝-后足评分均值由43分升至70分。
核心结论
- 翻修全踝关节成形术15年后生存率可接受,对经仔细选择的假体失败病例是有价值的治疗选择。
- 患者报告结局虽大幅改善,但未达到初次全踝关节成形术所报告的改善程度。
研究设计与样本
- 单中心回顾性队列研究,纳入2000年7月至2010年3月因初次全踝关节成形术失败行翻修术的116例患者(117踝),使用活动平台假体。
- 进行生存分析与危险因素评估,并在术前和末次随访评估临床表现与患者满意度。
主要发现
- 从初次翻修全踝关节成形术至末次随访平均15.0年(标准差3.0;11.2至20.5)。
- 翻修踝累积生存率5年81%(95%CI 74%至88%)、10年74%(65%至82%)、15年70%(61%至79%)。
- 初次全踝关节成形术前的合并症、无菌性松动、不稳或囊肿植骨是二次翻修最常见的危险因素。
- 术前疼痛视觉模拟评分中位数由6分(四分位距5至8)降至末次随访2分(四分位距0至5)(p < 0.001)。
- 美国足踝外科协会踝-后足评分均值由术前43分(标准差17)改善至末次随访70分(标准差20)(p < 0.001)。
临床怎么用
- 作者认为,翻修全踝关节成形术对经仔细选择的假体失败病例是有价值的治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Implant failure has become more common as the number of primary total ankle arthroplasties (TAAs) performed has increased. Although revision arthroplasty has gained attention for functional preservation, the long-term results remain unclear. This study aimed to assess the long-term outcomes of revision TAA using a mobile-bearing prosthesis in a considerably large cohort; the risk factors for failure were also determined. METHODS: This single-centre retrospective cohort study included 116 patients (117 ankles) who underwent revision TAA for failed primary TAA between July 2000 and March 2010. Survival analysis and risk factor assessment were performed, and clinical performance and patient satisfaction were evaluated preoperatively and at last follow-up. RESULTS: The mean duration from initial revision TAA to last follow-up was 15.0 years (SD 3.0; 11.2 to 20.5). The cumulative survival rates of the revised ankles were 81% (95% confidence interval (CI) 74% to 88%), 74% (65% to 82%), and 70% (61% to 79%) at five, ten, and 15 years, respectively. Comorbidities prior to primary TAA, aseptic loosening, instability, or grafting of cysts were found to be the most common risk factors for secondary revision. The median value for preoperative pain, as assessed using the visual analogue scale, declined from 6 (interquartile range (IQR) 5 to 8) to 2 (IQR 0 to 5) (p < 0.001) and the mean American Orthopaedic Foot and Ankle Society ankle-hindfoot score improved from 43 (SD 17) preoperatively to 70 (SD 20) (p < 0.001) at last follow-up. CONCLUSION: Revision TAA offers acceptable survival rates after 15 years; it therefore offers a valuable option for treatment of implant failure in carefully selected cases. Although patient-reported outcomes improve substantially, the degree of improvement reported following primary TAA is not achieved.
引用
- Hintermann B, Peterhans US, Susdorf R, et al. Survival and risk assessment in revision arthroplasty of the ankle. Bone Joint J. 2024. PMID: 38160692. doi:10.1302/0301-620X.106B1.BJJ-2023-0716.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。